Chlamydia

A chlamydia vaccine candidate showed promise in a first-in-human phase 1 trial, demonstrating safety and tolerability and provoking an immune response, researchers reported in The Lancet Infectious Diseases.

A text message-based intervention to improve self-management of pelvic inflammatory disease, or PID, among teens and young adults significantly decreased rates of Neisseria gonorrhoeae and Chlamydia trachomatis infection compared with standard treatment, according to findings from a randomized clinical trial published in JAMA Network Open.

SAN FRANCISCO — Researchers detected a “tremendous amount” of Mycoplasma genitalium from rectal swab specimens through off-label transcription mediated amplification, or TMA, testing in a cohort of young transgender women and men who have sex with men, or MSM, according to findings from the RADAR study presented at ASM Microbe.